ArticleAMB Express2025
Metabolic engineering of Parageobacillus thermoglucosidasius for thermophilic production of 1-butanol.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Analysis of Proteome Dynamics in Early-Stage Sporulation-Inhibited Variants ofInternational journal of molecular sciences · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
1-Butanol is a promising compound for the ongoing green transition due to its potential both as a fuel and as a platform chemical, serving as a common intermediate for the bulk production of other valuable products. In this study, the thermophilic bacterium Parageobacillus thermoglucosidasius DSM 2542 was engineered to produce 1-butanol by introducing a butanol-producing pathway with thermostable enzyme variations derived from various thermophilic microorganisms. To achieve successful metabolic engineering, the relevant genes were inserted into two different chromosomal locations, employing both constitutive and inducible promoter systems. The resulting strains exhibited varying 1-butanol production depending on the promoter system used for the first half of the genes, with titres reaching up to 0.4 g/L when working under oxygen-limiting conditions. This serves as a foundation for further metabolic optimization to utilize the strain under industrial conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.